As of 2025-09-15, the Relative Valuation of Ironwood Pharmaceuticals Inc (IRWD) is 1.10 USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.31 USD, the upside of Ironwood Pharmaceuticals Inc based on Relative Valuation is -16.0%.
The range of the Relative Valuation is (0.52) - 3.57 USD.
| Range | Selected | |
| Trailing P/E multiples | 10.6x - 15.1x | 13.3x |
| Forward P/E multiples | 11.8x - 16.6x | 13.2x |
| Fair Price | (0.52) - 3.57 | 1.10 |
| Upside | -139.4% - 172.6% | -16.0% |
| Date | P/E |
| 2025-09-12 | -26.99 |
| 2025-09-11 | -25.54 |
| 2025-09-10 | -23.69 |
| 2025-09-09 | -22.87 |
| 2025-09-08 | -23.28 |
| 2025-09-05 | -23.79 |
| 2025-09-04 | -22.66 |
| 2025-09-03 | -25.54 |
| 2025-09-02 | -26.99 |
| 2025-08-29 | -27.19 |
| 2025-08-28 | -27.19 |
| 2025-08-27 | -25.96 |
| 2025-08-26 | -26.16 |
| 2025-08-25 | -26.16 |
| 2025-08-22 | -26.16 |
| 2025-08-21 | -24.31 |
| 2025-08-20 | -22.66 |
| 2025-08-19 | -22.04 |
| 2025-08-18 | -23.28 |
| 2025-08-15 | -21.22 |
| 2025-08-14 | -22.04 |
| 2025-08-13 | -22.45 |
| 2025-08-12 | -20.24 |
| 2025-08-11 | -17.23 |
| 2025-08-08 | -18.48 |
| 2025-08-07 | -18.13 |
| 2025-08-06 | -16.58 |
| 2025-08-05 | -16.57 |
| 2025-08-04 | -15.46 |
| 2025-08-01 | -15.89 |
| 2025-07-31 | -15.74 |
| 2025-07-30 | -17.16 |
| 2025-07-29 | -18.33 |
| 2025-07-28 | -16.46 |
| 2025-07-25 | -16.82 |
| 2025-07-24 | -16.88 |
| 2025-07-23 | -17.86 |
| 2025-07-22 | -16.07 |
| 2025-07-21 | -15.73 |
| 2025-07-18 | -15.81 |
| 2025-07-17 | -16.29 |
| 2025-07-16 | -15.24 |
| 2025-07-15 | -14.15 |
| 2025-07-14 | -15.20 |
| 2025-07-11 | -15.50 |
| 2025-07-10 | -15.98 |
| 2025-07-09 | -16.57 |
| 2025-07-08 | -15.55 |
| 2025-07-07 | -14.69 |
| 2025-07-03 | -15.78 |